Related Experiment Video
Updated: Feb 12, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
Evgenia Lampropoulou1, Ioanna Logoviti1, Marina Koutsioumpa1,2
1Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, GR26504, Patras, Greece.
Abstract:
Pleiotrophin (PTN) stimulates endothelial cell migration through binding to receptor protein tyrosine phosphatase beta/zeta (RPTPβ/ζ) and ανβ3 integrin. Screening for proteins that interact with RPTPβ/ζ and potentially regulate PTN signaling, through mass spectrometry analysis, identified cyclin-dependent kinase 5 (CDK5) activator p35 among the proteins displaying high sequence coverage. Interaction of p35 with the serine/threonine kinase CDK5 leads to CDK5 activation, known to be implicated in cell migration. Protein immunoprecipitation and proximity ligation assays verified p35-RPTPβ/ζ interaction and revealed the molecular association of CDK5 and RPTPβ/ζ. In endothelial cells, PTN activates CDK5 in an RPTPβ/ζ- and phosphoinositide 3-kinase (PI3K)-dependent manner. On the other hand, c-Src, ανβ3 and ERK1/2 do not mediate the PTN-induced CDK5 activation. Pharmacological and genetic inhibition of CDK5 abolished PTN-induced endothelial cell migration, suggesting that CDK5 mediates PTN stimulatory effect. A new pyrrolo[2,3-α]carbazole derivative previously identified as a CDK1 inhibitor, was found to suppress CDK5 activity and eliminate PTN stimulatory effect on cell migration, warranting its further evaluation as a new CDK5 inhibitor. Collectively, our data reveal that CDK5 is activated by PTN, in an RPTPβ/ζ-dependent manner, regulates PTN-induced cell migration and is an attractive target for the inhibition of PTN pro-angiogenic properties.
Insights
Pleiotrophin (PTN) activates cyclin-dependent kinase 5 (CDK5) via receptor RPTPβ/ζ, promoting endothelial cell migration. Inhibiting CDK5 blocks PTN
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Pleiotrophin (PTN) is a growth factor that stimulates endothelial cell migration.
- PTN signaling involves receptor protein tyrosine phosphatase beta/zeta (RPTPβ/ζ) and ανβ3 integrin.
- Cyclin-dependent kinase 5 (CDK5) is implicated in cell migration.
Purpose of the Study:
- To identify proteins interacting with RPTPβ/ζ and regulating PTN signaling.
- To investigate the role of CDK5 in PTN-induced endothelial cell migration.
- To evaluate a novel pyrrolo[2,3-α]carbazole derivative as a potential CDK5 inhibitor.
Main Methods:
- Mass spectrometry to identify interacting proteins.
- Protein immunoprecipitation and proximity ligation assays to confirm interactions.
- Pharmacological and genetic inhibition of CDK5 to assess its role in cell migration.
Main Results:
- Cyclin-dependent kinase 5 (CDK5) activator p35 was identified as an RPTPβ/ζ interacting protein.
- PTN activates CDK5 in endothelial cells via RPTPβ/ζ and phosphoinositide 3-kinase (PI3K) signaling.
- CDK5 inhibition abolished PTN-induced endothelial cell migration.
- A pyrrolo[2,3-α]carbazole derivative suppressed CDK5 activity and PTN-induced migration.
Conclusions:
- CDK5 is a key mediator of PTN-induced endothelial cell migration.
- PTN activates CDK5 through an RPTPβ/ζ-dependent pathway.
- CDK5 is a potential therapeutic target for inhibiting PTN's pro-angiogenic effects.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Cell Migration
Cell Migration
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...

